| Dr Jennifer Ann Lehnhardt, DDS | |
|
103 W Jefferson Ave Ste A, Belgrade, MT 59714-4419 | |
| (406) 388-3005 | |
| (406) 388-4265 |
| Full Name | Dr Jennifer Ann Lehnhardt |
|---|---|
| Gender | Female |
| Speciality | Dentist - Oral And Maxillofacial Surgery |
| Location | 103 W Jefferson Ave Ste A, Belgrade, Montana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003239732 | NPI | - | NPPES |
| 1003239732 | Medicaid | MT |
| Entity Name | Stanford Health Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437292927 PECOS PAC ID: 6709797491 Enrollment ID: O20031124000348 |
News Archive
A new combination vaccine may reduce the number of injections required to keep infants and toddlers up to date with the United States infant immunization schedule recommended by the Centers for Disease Control and Prevention. In a phase III trial reported in the August 2015 issue of Pediatrics, the vaccine was determined to be effective, safe and well-tolerated. Gary S. Marshall, M.D., professor of pediatrics at the University of Louisville, was the principal investigator of the multi-center trial and first author of the report.
Agilent Technologies Inc. today introduced the 5975T Low Thermal Mass (LTM) Gas Chromatography/Mass Spectrometry Detector (GC/MSD), the industry's first commercial transportable GC/MS system that delivers laboratory-quality analysis. Using proprietary LTM technology, Agilent has developed the 5975T LTM GC/MS to be smaller, more rugged and to consume less power than in-lab GC/MS instruments, yet capable of the same high-quality performance in the field.
The Wall Street Journal profiles the case of a man infected with extensively drug-resistant tuberculosis (XDR-TB) who is being detained in South Texas after a "three-month odyssey through 13 countries - from his homeland of Nepal through South Asia, Brazil, Mexico, and finally into Texas - show[ing] the way in which dangerous new strains of the disease can migrate across the world unchecked."
As scientists scramble to get a Zika virus vaccine into human trials by the end of the summer, a team of researchers is working on the first-ever vaccine to prevent another insect-borne disease - Leishmaniasis - from gaining a similar foothold in the Americas.
In a study that could lead to new therapeutic targets for patients with the cystic fibrosis, a research team from the University of California, San Diego School of Medicine has identified a defective signaling pathway that contributes to disease severity.
› Verified 3 days ago
| Entity Name | Lpch Medical Group Div Of Lucile |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417907940 PECOS PAC ID: 0840298543 Enrollment ID: O20061113000232 |
News Archive
A new combination vaccine may reduce the number of injections required to keep infants and toddlers up to date with the United States infant immunization schedule recommended by the Centers for Disease Control and Prevention. In a phase III trial reported in the August 2015 issue of Pediatrics, the vaccine was determined to be effective, safe and well-tolerated. Gary S. Marshall, M.D., professor of pediatrics at the University of Louisville, was the principal investigator of the multi-center trial and first author of the report.
Agilent Technologies Inc. today introduced the 5975T Low Thermal Mass (LTM) Gas Chromatography/Mass Spectrometry Detector (GC/MSD), the industry's first commercial transportable GC/MS system that delivers laboratory-quality analysis. Using proprietary LTM technology, Agilent has developed the 5975T LTM GC/MS to be smaller, more rugged and to consume less power than in-lab GC/MS instruments, yet capable of the same high-quality performance in the field.
The Wall Street Journal profiles the case of a man infected with extensively drug-resistant tuberculosis (XDR-TB) who is being detained in South Texas after a "three-month odyssey through 13 countries - from his homeland of Nepal through South Asia, Brazil, Mexico, and finally into Texas - show[ing] the way in which dangerous new strains of the disease can migrate across the world unchecked."
As scientists scramble to get a Zika virus vaccine into human trials by the end of the summer, a team of researchers is working on the first-ever vaccine to prevent another insect-borne disease - Leishmaniasis - from gaining a similar foothold in the Americas.
In a study that could lead to new therapeutic targets for patients with the cystic fibrosis, a research team from the University of California, San Diego School of Medicine has identified a defective signaling pathway that contributes to disease severity.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jennifer Ann Lehnhardt, DDS 3997 Valley Commons Dr Ste A, Bozeman, MT 59718-5617 Ph: (406) 404-1186 | Dr Jennifer Ann Lehnhardt, DDS 103 W Jefferson Ave Ste A, Belgrade, MT 59714-4419 Ph: (406) 388-3005 |
News Archive
A new combination vaccine may reduce the number of injections required to keep infants and toddlers up to date with the United States infant immunization schedule recommended by the Centers for Disease Control and Prevention. In a phase III trial reported in the August 2015 issue of Pediatrics, the vaccine was determined to be effective, safe and well-tolerated. Gary S. Marshall, M.D., professor of pediatrics at the University of Louisville, was the principal investigator of the multi-center trial and first author of the report.
Agilent Technologies Inc. today introduced the 5975T Low Thermal Mass (LTM) Gas Chromatography/Mass Spectrometry Detector (GC/MSD), the industry's first commercial transportable GC/MS system that delivers laboratory-quality analysis. Using proprietary LTM technology, Agilent has developed the 5975T LTM GC/MS to be smaller, more rugged and to consume less power than in-lab GC/MS instruments, yet capable of the same high-quality performance in the field.
The Wall Street Journal profiles the case of a man infected with extensively drug-resistant tuberculosis (XDR-TB) who is being detained in South Texas after a "three-month odyssey through 13 countries - from his homeland of Nepal through South Asia, Brazil, Mexico, and finally into Texas - show[ing] the way in which dangerous new strains of the disease can migrate across the world unchecked."
As scientists scramble to get a Zika virus vaccine into human trials by the end of the summer, a team of researchers is working on the first-ever vaccine to prevent another insect-borne disease - Leishmaniasis - from gaining a similar foothold in the Americas.
In a study that could lead to new therapeutic targets for patients with the cystic fibrosis, a research team from the University of California, San Diego School of Medicine has identified a defective signaling pathway that contributes to disease severity.
› Verified 3 days ago
Dr. Robert Andersen, D.M.D. Dentist Medicare: Medicare Enrolled Practice Location: 19 E Main St, Belgrade, MT 59714 Phone: 406-922-0820 Fax: 406-823-6305 | |
Dr. Dane C Kinghorn, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 412 W Main St, Suite 1, Belgrade, MT 59714 Phone: 406-388-8006 Fax: 406-388-8712 | |
Cassandra Murphy, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 103 W Jefferson Ave, Belgrade, MT 59714 Phone: 315-877-4139 | |
Jay Q Lister, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 103 W Jefferson Ave, Belgrade, MT 59714 Phone: 406-388-4064 | |
Patrick Ray Hays, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 412 W Main St, Suite 1, Belgrade, MT 59714 Phone: 406-388-8006 | |
Dr. Kenneth L. Hasting, D.D.S Dentist Medicare: Not Enrolled in Medicare Practice Location: 8160 Springhill Community Rd, Belgrade, MT 59714 Phone: 406-556-1100 Fax: 406-586-3543 |